Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Blood Specimen Collection × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasms 11 Colorectal Neoplasms 7 Myelodysplastic Syndromes 5 Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thrombosis 2 Skin Neoplasms 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Desmoid Tumors 2 Carcinoma, Squamous Cell 2 Carcinoma, Renal Cell 2 COVID-19 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Upper AerodigestiveTract Cancer 1 Triple Negative Breast Neoplasms 1

Interventions

Temozolomide 44 Radiotherapy 18 Magnetic Resonance Spectroscopy 17 Radiation 13 Specimen Handling 12 pembrolizumab 11 Bevacizumab 7 Cyclophosphamide 6 Nivolumab 5 Lomustine 5 Biopsy 4 niraparib 3 fludarabine 3 abemaciclib 3 Surgical Procedures, Operative 3 Radiotherapy, Intensity-Modulated 3 Photons 3 Ipilimumab 3 Etoposide 3 Diet, Ketogenic 3 Carboplatin 3 trametinib 2 selinexor 2 regorafenib 2 olaparib 2 dabrafenib 2 cemiplimab 2 cabozantinib 2 atezolizumab 2 antisecretory factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472387 2026-03-16

Andro-iGlio

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡